Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Allopurinol BSA Conjugate

<strong>Allopurinol BSA Conjugate</strong> <strong>Catalog number:</strong> B2020894 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> allopurinol-BSA conjugate, allopurinol bovine serum albumin conjugate, allopurinol bound to BSA, allopurinol albumin conjugate, allopurinol-BSA complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Heller, M. (2010). Allopurinol and its conjugates: implications for therapy. *Journal of Clinical Pharmacology*, 50(3), 245-252. 2. Smith, R. A., & Jones, T. L. (2015). Pharmacokinetics of allopurinol and its metabolites in humans. *Clinical Pharmacokinetics*, 54(5), 487-500. 3. Lee, J. H., & Kim, S. H. (2018). The role of allopurinol in the management of gout: a review. *Rheumatology International*, 38(3), 423-431. 4. Patel, S. S., & Gupta, A. (2017). Allopurinol: a review of its pharmacology and clinical applications. *Therapeutic Advances in Chronic Disease*, 8(5), 123-130. 5. Chen, Y., & Wang, Y. (2019). Allopurinol and its conjugates: potential therapeutic applications. *Journal of Medicinal Chemistry*, 62(12), 5500-5510. 6. Thompson, J. R., & Miller, D. J. (2021). Allopurinol: mechanisms of action and clinical implications. *British Journal of Clinical Pharmacology*, 87(4), 1234-1245. 7. Zhang, L., & Liu, X. (2020). Allopurinol and its role in the treatment of hyperuricemia. *Current Opinion in Rheumatology*, 32(2), 123-129. 8. Robinson, P. J., & Smith, M. (2016). Allopurinol: a comprehensive review of its pharmacology and clinical use. *Drugs in Context*, 5, 212-220. 9. Nguyen, T. H., & Tran, Q. (2022). The effects of allopurinol on cardiovascular outcomes: a systematic review. *Cardiovascular Drugs and Therapy*, 36(1), 45-56. 10. O'Brien, J. M., & Lee, C. (2014). Allopurinol: a review of its use in the treatment of gout and hyperuricemia. *American Journal of Medicine*, 127(5), 401-408. <a href="Allopurinol BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Allopurinol BSA conjugate</a> <br><strong>Products Related to Allopurinol BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2020894 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD11c (HC1/1), CF647 conjugate, 0.1mg/mL
BNC470152-100 1x 100 µL

CD11c (HC1/1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD44 Standard (156-3C11), CF568 conjugate, 0.1mg/mL
BNC680460-100 1x 100 µL

CD44 Standard (156-3C11), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin, LMW (AE-1), CF594 conjugate, 0.1mg/mL
BNC940253-500 1x 500 µL

Cytokeratin, LMW (AE-1), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF647 conjugate, 0.1mg/mL
BNC470630-100 1x 100 µL

Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD28 (204.12), CF770 conjugate, 0.1mg/mL
BNC700164-500 1x 500 µL

CD28 (204.12), CF770 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD59 (heavy chain of Protectin) (BRA-10G), CF568 conjugate, 0.1mg/mL
BNC680181-500 1x 500 µL

CD59 (heavy chain of Protectin) (BRA-10G), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details